Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer - International considerations amongst upper middle- and high-income countries (UMIC and HIC)

• मुख्य लेखकों: Jeffrey C.H. Goh (लेखक), Charlie Gourley (लेखक), David S P Tan (लेखक), Angélica Nogueira-Rodrigues (लेखक), Hesham Elghazaly (लेखक), Marc Edy Pierre (लेखक), Gonzalo Giornelli (लेखक), Byoung-Gie Kim (लेखक), Flavia Morales-Vasquez (लेखक), Alexandra Tyulyandina (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2022-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The incidence and mortality rates of ovarian cancer are increasing globally. Ovarian cancer is diagnosed at an advanced stage in 80% of women. After standard, platinum-based, front-line chemotherapy, poly (ADP-ribose) polymerase (PARP) inhibitors and antiangiogenic agents are successfully employed a...